CinCor Pharma Inc. (CINC)
CinCor Pharma Statistics
Share Statistics
CinCor Pharma has 43.76M shares outstanding. The number of shares has increased by 0% in one year.
| 43.76M |
| 0% |
| 0% |
| n/a |
| 17.91M |
| 4,432 |
| 0.71% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -11.26 and the forward PE ratio is null. CinCor Pharma's PEG ratio is -0.23.
| -11.26 |
| n/a |
| 0 |
| n/a |
| -8.89 |
| -18.37 |
| -0.23 |
Enterprise Valuation
CinCor Pharma has an Enterprise Value (EV) of 430.1M.
| 0 |
| -12.42 |
| -13.94 |
| -13.94 |
Financial Position
The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.
| 8.53 |
| 8.53 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is 79.02% and Return on Invested Capital is 66.69%.
| 79.02% |
| -35.68% |
| 66.69% |
| n/a |
| $-2,649,864.89 |
| 19 |
| 0 |
| n/a |
Taxes
| -21.64K |
| 0.04% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0, so CinCor Pharma's price volatility has been lower than the market average.
| 0 |
| n/a |
| 22.81 |
| 24.66 |
| 69.26 |
| 625,748 |
Balance Sheet
The company has 136.61M in cash and 0 in debt, giving a net cash position of 136.61M.
| 136.61M |
| n/a |
| n/a |
| -77.7M |
| 529.12M |
| 518.84M |
Cash Flow
In the last 12 months, operating cash flow was -30.85M and capital expenditures 0, giving a free cash flow of -30.85M.
| -30.85M |
| n/a |
| -30.85M |
| -0.87 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
CINC does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -8.88% |
| -5.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| 7.59 |
| -73.88% |
Scores
| 75.23 |
| 2 |